Filters: Author is Fiellin, David A [Clear All Filters]
"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?" Drug and alcohol dependence 79, no. 1 (2005): 113-6. Abstract
"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment." Journal of general internal medicine 25, no. 9 (2010): 936-41. Abstract
"Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort." Drug and alcohol dependence 110, no. 3 (2010): 208-20. Abstract
"Patient satisfaction with primary care office-based buprenorphine/naloxone treatment." Journal of general internal medicine 22, no. 2 (2007): 242-5. Abstract
"Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study." Drug and alcohol dependence (2013). Abstract
"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
"Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 22, no. 3 (2013): 212-7. Abstract
"Opioids, chronic pain, and addiction in primary care." The journal of pain : official journal of the American Pain Society 11, no. 12 (2010): 1442-50. Abstract
"Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S91-7. Abstract
"Opioid use disorder in the United States: insurance status and treatment access." Drug and alcohol dependence 94, no. 1-3 (2008): 207-13. Abstract
"Opioid substitution therapy-time to replace the term." Lancet 385, no. 9977 (2015): 1508-9.
"Opioid doses and increased risk for overdose." Annals of internal medicine 153, no. 1 (2010): 59; author reply 59-60.
"Opioid dependence: rationale for and efficacy of existing and new treatments." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S173-7. Abstract
"Opioid Dependence Treatment in the Emergency Department--Reply." JAMA 314, no. 8 (2015): 835.
"Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?" CNS drugs 22, no. 2 (2008): 99-111. Abstract
"Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men." AIDS and behavior 20, no. 3 (2016): 504-11. Abstract
"Nonmedical use of prescription opioids and pain in veterans with and without HIV." Pain 152, no. 5 (2011): 1133-8. Abstract
"Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates." Archives of internal medicine 171, no. 11 (2011): 1034-6.
"Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates." Drug and alcohol dependence 90, no. 2-3 (2007): 280-7. Abstract
"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates." Drug and alcohol dependence 94, no. 1-3 (2008): 38-47. Abstract
"Non-medical use of prescription opioids is associated with heroin initiation among US veterans: a prospective cohort study." Addiction (Abingdon, England) (2016). Abstract
"The next therapeutic challenge in HIV: polypharmacy." Drugs & aging 30, no. 8 (2013): 613-28. Abstract
"New federal initiatives to enhance the medical treatment of opioid dependence." Annals of internal medicine 137, no. 8 (2002): 688-92. Abstract
"Narrative review: buprenorphine for opioid-dependent patients in office practice." Annals of internal medicine 148, no. 9 (2008): 662-70. Abstract
"Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine." American journal of preventive medicine 44, no. 1 Suppl 2 (2013): S86-90.
"Methadone syrup injection in Australia: a sentinel finding?" Addiction (Abingdon, England) 98, no. 4 (2003): 385-6.
"Methadone safety: a clinical practice guideline from the american pain society and college on problems of drug dependence, in collaboration with the heart rhythm society." The journal of pain : official journal of the American Pain Society 15, no. 4 (2014): 321-37. Abstract
"A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 20, no. 4 (2011): 343-56. Abstract
"Mental health after deployment to Iraq or Afghanistan." JAMA : the journal of the American Medical Association 296, no. 5 (2006): 515; author reply 516.
"Measuring Alcohol Consumption Using Timeline Followback in Non-Treatment-Seeking Medical Clinic Patients With and Without HIV Infection: 7-, 14-, or 30-day Recall." Journal of studies on alcohol and drugs 74, no. 3 (2013): 500-504. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients." Journal of acquired immune deficiency syndromes (1999) 69, no. 2 (2015): 223-33. Abstract
"Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis." AIDS (London, England) (2017). Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Integrating buprenorphine treatment into office-based practice: a qualitative study." Journal of general internal medicine 24, no. 2 (2009): 218-25. Abstract
"Initial strategies for integrating buprenorphine into HIV care settings in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S191-6. Abstract
"Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population." The Journal of clinical psychiatry (2014). Abstract
"Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy." Journal of rehabilitation research and development 53, no. 1 (2016): 127-36. Abstract
"Increased Hospital and Emergency Department Utilization by Individuals with Recent Criminal Justice Involvement: Results of a National Survey." Journal of general internal medicine (2014). Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S39-45. Abstract
"Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics." Addiction science & clinical practice 11, no. 1 (2016): 1. Abstract
"The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection." Journal of substance abuse treatment (2014). Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients." Drug and alcohol dependence (2014). Abstract
"Human Immunodeficiency Virus-Testing Practices Among Buprenorphine-prescribing Physicians." Journal of addiction medicine (2012). Abstract
"Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians." Journal of addiction medicine 6, no. 2 (2012): 159-65. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment." Journal of addiction medicine 7, no. 6 (2013): 410-6. Abstract
